Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

People's Journal of Scientific Research
Published December 1, 2015 | Version v1
Journal article Open

Intranasal Midazolam Versus Intravenous Diazepam for the Treatment of Acute Seizures in Paediatric Patients

Creators

Description

The objective of this study was to measure the time needed to control seizure attacks using intranasal midazolam compared with intravenous diazepam and to evaluate the probable side effects. This study was conducted as a non blind randomized clinical trial among 50 patients coming to MLBMC, Jhansi. The patients were 2 months to 15 years old children coming to our emergency department suffering from an acute seizure episode. Intranasal midazolam was administered 0.2 mg/kg equally dropped in both nostrils for group A and intravenous diazepam was administered 0.3mg/kg via intravenous line for group B. Choice of drugs for patient was based on randomization. After both treatments, the time needed to control the seizure was registered by the practitioner. Pulse rate and oxygen saturation were recorded at patient's entrance and in minutes 5 and 10 after drug administration. The mean time from physician contact to cessation of seizures was significantly shorter in the midazolam group (3.9880(SD 1.38784) minutes), than the diazepam group (5.4840 (SD 2.33661)min). The mean time from drug administration to cessation of seizures was significantly sooner (3.1160 (SD 0.97112)min) in the diazepam group than the midazolam group (3.8720 (SD 1.57229) min). No significant side effects were observed in either group. Seizures were controlled more quickly with intravenous diazepam than with intranasal midazolam, although midazolam was as safe and effective as diazepam. The overall time to cessation of seizures after arrival at hospital was faster with intranasal midazolam than with intravenous diazepam due to its shorter time of adminstration.

Files

6-10.pdf

Files (56.6 kB)

Name Size Download all
md5:3d7678de8cbcd585739ea049a5f27bd2
56.6 kB Preview Download

Additional details

References

  • 1. Kliegman RM, Behrman RE, Stanton BF, Geme III JW, Schor NF; Seizures in childhood. In: Nelson Textbook of Pediatrics; 19 Edn.; Elsevier, Philadelphia, 2011; 2013.
  • 2. Ever AS, Michel C, Balser JR. Bendiazepines.In: Goodman and Gilman`s The Pharmacological Basis of Therapeutics; 11 Edn.; 2003:13:341;pp.403-411.
  • 3. Rey E, Delaunay L. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration; Eur J Clin Pharmacol 1991;41(IV):355-357.
  • 4. Scheepers M. Is intranasal midazolam an effective rescue medication for adolescent with severe epilepsy?; J Pediatr Neurol; 2000; 9(VI); 417-422
  • 5. Bhattacharyya M, Kalra V, Gulati S ;Intranasal midazolam versus rectal and intravenous diazepam in acute childhood seizures; Pediatr Neurol 2006;34 (5):355-359.
  • 6. Koren G. Intranasal midazolam for febrile seizures. A step forward in treating a common and distressing condition; BMIJ 2000;321(7253);pp64-65.
  • 7. Harbord MG, Kyrkou NE, Kyrkou MR, Kay D, Coulthard KP. Use of intranasal midazolam to treat acute seizures in paediatric community settings; J Paediatr Child Health 2004;40(9-10);556-558.
  • 8. Wermeling DP, Miller JL, Rudy AC. Intranasal delivery ; Drug Delivery Technology 2005; 5(3):44- 49.
  • 9. Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998; 35(1):37-47.
  • 10. Lahat E, Goldman M, Barr J. Intranasal midazolam for childhood seizures; Lancet;1998; pp.352-620.
  • 11. Behrman RE, Kliegman RM, Stanton BF, Geme III JW, Schor NF. seizures in childhood.In: Nelson Text Book of Paediatrics; 18th Edn.; Thomsom Press, Pennsylvania; 2008; pp(2457-2475)
  • 12. Holsti M, Sill B. Prehospital intranasal midazolam for treating pediatric seizures; J Pediatric Care Emer Care 2007; 23(3):148-153
  • 13. Chamberlain JM, Altieri MA, Futterman G, Young GM. A prospective randomized study comparing intra-muscular midazolam with intravenous diazepam for the treatment of seizures in children; Pediatr Emerg Care 1997;13:92-94.
  • 14. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study; Br Med J 2000; 321:83-86.
  • 15. Fisgin T, Gurer Y. Nasal midazolam effects on childhood acute seizures; J Child Neurol 2000;15(12), 833 -835
  • 16. Kutlu NO, Yakini. Intranasal midazolam for prolonged convulsive seizures; Brain Dev. 2000; 22(6):359-361
  • 17. Mittal P, Manohar R, Rawat AK; Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures. Indian J Pediatr 2006;73:75-78.
  • 18. Jawad S, Oxley J, Wilson J, Richens A. A pharmacodynamic evaluation of midazolam as anti - epileptic compound. J Neurol 1988;49:1050-10.
  • 19. Mahoudian T, Zadeh MM. Comparison of Intranasal midazolam with intravenous diazepam for treating acute seizures in children; Epilepsy Behav 2004;5(2):235-255.